In a hopeful sign for demand for more safe, effective antibiotics for humans, researchers at The University of Texas at Austin have leveraged artificial intelligence (AI) to develop a new drug that already is showing promise in animal trials.
Publishing their results in Nature Biomedical Engineering, the scientists describe using a large language model – an AI tool like the one that powers ChatGPT – to engineer a version of a bacteria-killing drug that was previously toxic in humans, so that it would be safe to use.